Our results support a model by which ApoE compensates for the loss of ApoB function through transcriptional activation and post-translational modifications and provide new insights into how hepatic lipid content is regulated by ApoE, whose abnormalities are implicated in metabolic diseases. The gene discussed is APOB; the disease is Other metabolic disease.